Pancreatic Cancer Research

ResearcherUniversity of Alabama at BirminghamNo recent work listed

Ruiwen Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5323-0772; OpenAlex author ID A5088978867; NIH RePORTER profile ID 1984443. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
1
Labs led
2
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 3 papers, 1 grant

Papers 6

  1. QSAR Studies of New Pyrido[3,4-b]indole Derivatives as Inhibitors of Colon and Pancreatic Cancer Cell Proliferation. Co-author DOI 10.1007/s00044-018-2250-5↗
  2. Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy. Last author DOI 10.1158/0008-5472.can-17-3939↗
  3. Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy. Last author DOI 10.3389/fphar.2018.00005↗
  4. Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment. Co-author PMID 27293990↗
  5. KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology. Last author DOI 10.1371/journal.pone.0044883↗
  6. Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutic… Co-author DOI 10.1021/mp200193u↗

Grants 1

  1. Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy R01CA186662↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John K Buolamwini · 2 shared papers, 2018 · strength 0.20
  2. Hemantkumar S. Deokar · 2 shared papers, 2018 · strength 0.20
  3. Jiang‐Jiang Qin · 2 shared papers, 2018 · strength 0.18
  4. Ming‐Hai Wang · 3 shared papers, 2011–2016 · strength 0.14
  5. Hangping Yao · 2 shared papers, 2011–2016 · strength 0.11
  6. Wei Wang · 1 shared paper, 2018 · strength 0.08
  7. Snehal Padhye · 1 shared paper, 2011 · strength 0.03
  8. Hongxia Xu · 1 shared paper, 2012 · strength 0.03
  9. Wei Wang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.